Castle Biosciences Stock Widgets and Gadgets
| CSTL Stock | USD 32.26 0.39 1.22% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CSTL Castle Biosciences
- Latest Castle Biosciences, Inc. is a Great Momentum Stock Should You Buy
- CSTL 32.26 0.39
- Low 31.62
- High 32.91
- Volume 274.1 K
- Alpha 0.62
- Beta 2.07
- Return On Equity -0.0077
- Return On Asset -0.0216
- Profit Margin (0.01) %
- Operating Margin 0.06 %
- Current Valuation 649.47 M
- Shares Outstanding 27.74 M
- Shares Owned By Insiders 3.30 %
- Shares Owned By Institutions 94.33 %
- Number Of Shares Shorted 1.61 M
- Price To Earning 87.86 X
- Price To Book 2.09 X
- Price To Sales 3.11 X
- Revenue 219.79 M
- Gross Profit 105.03 M
- EBITDA (55.65 M)
- Net Income (57.47 M)
- Cash And Equivalents 273.17 M
- Cash Per Share 10.39 X
- Total Debt 15.31 M
- Debt To Equity 0.02 %
- Current Ratio 11.08 X
- Book Value Per Share 15.30 X
- Cash Flow From Operations (135 K)
- Short Ratio 4.87 X
- Earnings Per Share (0.12) X
- Target Price 36.11
- Number Of Employees 703
- Beta 1.03
- Market Capitalization 894.79 M
- Total Asset 477.81 M
- Retained Earnings (218.37 M)
- Working Capital 247.97 M
- Current Asset 125.89 M
- Current Liabilities 13.31 M
- Net Asset 477.81 M
- Accumulation Distribution 10742.94
- Daily Balance Of Power 0.3023
- Rate Of Daily Change 1.01
- Day Median Price 32.27
- Day Typical Price 32.26
- Price Action Indicator 0.19
- Period Momentum Indicator 0.39
- Relative Strength Index 59.48
Market Snapshot Widget Example
DAX Index Germany | 19,422 0.2 | |
Taiwan Weighted Taiwan | 23,535 0.03 | |
PSI 20 Stock Portugal | 6,555 1.12 | |
CROBEX Croatia | 3,043 0.27 | |
Budapest SE Hungary | 73,846 0.19 | |
IDX 30 Jakarta Indonesia | 492.14 0.42 | |
ISEQ 20 Price Ireland | 1,655 0.03 | |
NYSE Comp USA | 19,653 0.34 | |
Tel Aviv 35 Israel | 2,155 1 | |
Coreshares Index Tracker South Afric | 1,110 0.89 | |
IPC MEXICO Mexico | 52,369 0.05 | |
KL Technology Malaysia | 59.90 0.32 | |
IBEX 35 Index Spain | 11,833 0.07 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,583 0.48 | |
SPASX Dividend Opportunities Australia | 1,663 1.56 | |
HNX 30 Vietnam | 492.99 1.07 | |
Bucharest BET-NG Romania | 1,228 0.27 | |
AMS Small Cap Netherlands | 1,258 0.18 | |
Oslo Exchange Mutual Norway | 1,400 0.24 | |
BEL Small Belgium | 8,668 0.95 | |
Basic Materials Brazil | 5,631 0.04 | |
Swiss Leader Price Switzerland | 1,984 0.71 | |
Fondo Mutuo ETF Chile | 1,384 0.07 | |
Athens General Comp Greece | 1,415 1.67 | |
Stock Exchange Of Thailand | 1,470 1.24 | |
PX Prague Stock Czech Repub | 1,628 0.01 | |
THE PHILIPPINE STOCK Philippines | 7,413 0.09 | |
WIG 30 Poland | 2,852 1.28 | |
BIST Electricity Turkey | 459.70 2.94 |
Investing Ideas
In addition to having Castle Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Castle Biosciences
Compare Castle Biosciences To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (0.12) | Revenue Per Share 10.554 | Quarterly Revenue Growth 0.735 | Return On Assets (0.02) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.